{"abstract": "AbbVie agreed on Friday to buy the Irish drug maker Shire for around $54 billion. | Alibaba has pushed its I.P.O. to September. | Growth in wealth management bolstered Morgan Stanley\u2019s second-quarter profit. | New York State\u2019s top financial regulator has proposed regulations for virtual currency companies.", "web_url": "https://dealbook.nytimes.com/2014/07/18/morning-agenda-abbvie-wins-deal-for-shire/", "snippet": "AbbVie agreed on Friday to buy the Irish drug maker Shire for around $54 billion. | Alibaba has pushed its I.P.O. to September. | Growth in wealth management bolstered Morgan Stanley\u2019s second-quarter profit. | New York State\u2019s top financial regula...", "lead_paragraph": " ABBVIE CLINCHES $54 BILLION DEAL FOR SHIRE | The pharmaceutical giant AbbVie agreed on Friday to buy the Irish drug maker Shire for around $54 billion, the biggest takeover deal so far this year, Mark Scott writes in DealBook. The deal will allow AbbVie, based outside Chicago, to reincorporate in Britain and reduce its tax bill, representing the largest ever inversion as United States companies rush to pursue the financial advantages of moving overseas, even as lawmakers move to crack down on the increasingly popular maneuver.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Morning Agenda: AbbVie Wins Deal for Shire", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2014-07-18T11:24:31+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Sydney Ember", "person": [{"firstname": "Sydney", "middlename": null, "lastname": "Ember", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/7a8785af-e0f5-5620-a0db-b43a6951f75a", "word_count": 1890, "uri": "nyt://article/7a8785af-e0f5-5620-a0db-b43a6951f75a"}